AU746595B2 - IL-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders - Google Patents

IL-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders Download PDF

Info

Publication number
AU746595B2
AU746595B2 AU56891/98A AU5689198A AU746595B2 AU 746595 B2 AU746595 B2 AU 746595B2 AU 56891/98 A AU56891/98 A AU 56891/98A AU 5689198 A AU5689198 A AU 5689198A AU 746595 B2 AU746595 B2 AU 746595B2
Authority
AU
Australia
Prior art keywords
seq
leu
ser
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU56891/98A
Other languages
English (en)
Other versions
AU5689198A (en
Inventor
Luigi Grasso
Kenneth J. Holroyd
Roy Clifford Levitt
Nicholas C. Nicolaides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genaera Corp
Original Assignee
Genaera Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaera Corp filed Critical Genaera Corp
Priority claimed from PCT/US1997/021992 external-priority patent/WO1998024904A2/en
Publication of AU5689198A publication Critical patent/AU5689198A/en
Assigned to GENAERA CORPORATION reassignment GENAERA CORPORATION Alteration of Name(s) of Applicant(s) under S113 Assignors: MAGAININ PHARMACEUTICALS, INC.
Application granted granted Critical
Publication of AU746595B2 publication Critical patent/AU746595B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU56891/98A 1996-12-02 1997-12-02 IL-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders Ceased AU746595B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3222496P 1996-12-02 1996-12-02
US60/032224 1996-12-02
US98087297A 1997-12-01 1997-12-01
US08/980872 1997-12-01
PCT/US1997/021992 WO1998024904A2 (en) 1996-12-02 1997-12-02 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2002300303A Division AU2002300303A1 (en) 1996-12-02 2002-07-29 IL-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders

Publications (2)

Publication Number Publication Date
AU5689198A AU5689198A (en) 1998-06-29
AU746595B2 true AU746595B2 (en) 2002-05-02

Family

ID=26708147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56891/98A Ceased AU746595B2 (en) 1996-12-02 1997-12-02 IL-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders

Country Status (8)

Country Link
EP (1) EP0942979A2 (de)
JP (2) JP4552076B2 (de)
AT (1) ATE471982T1 (de)
AU (1) AU746595B2 (de)
CA (1) CA2271952C (de)
DE (1) DE69739920D1 (de)
ES (1) ES2347962T3 (de)
PT (1) PT1471144E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119040500B (zh) * 2024-07-18 2026-04-17 中国农业科学院作物科学研究所 与大豆种子油份、蛋白含量和百粒重相关的snp分子标记与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2241329A3 (de) * 1995-08-24 2011-03-09 Ligand Pharmaceuticals Incorporated Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen

Also Published As

Publication number Publication date
AU5689198A (en) 1998-06-29
JP2009159976A (ja) 2009-07-23
PT1471144E (pt) 2010-08-17
CA2271952C (en) 2010-04-06
CA2271952A1 (en) 1998-06-11
ATE471982T1 (de) 2010-07-15
EP0942979A2 (de) 1999-09-22
ES2347962T3 (es) 2010-11-26
DE69739920D1 (de) 2010-08-05
JP2002514911A (ja) 2002-05-21
JP4552076B2 (ja) 2010-09-29

Similar Documents

Publication Publication Date Title
US7704710B2 (en) Interleukin-9 receptor mutants
US6645492B2 (en) Methods of treating asthma with interleukin-9 receptor antibodies
JP4813380B2 (ja) 喘息および関連疾患を含むアトピー性アレルギーを治療するための標的としての喘息関連因子
WO1998024904A9 (en) Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
Grasso et al. Molecular analysis of human interleukin-9 receptor transcripts in peripheral blood mononuclear cells: identification of a splice variant encoding for a nonfunctional cell surface receptor
EP1471144B1 (de) Biologische Variabilität von Asthma-assoziiertem Faktor 2 AAF2 (IL-9 Rezeptor) nützlich für die Behandlung und Diagnose von atopischen Allergien wie Asthma und Asthma-ähnlichen Erkrankungen
CA2271952C (en) Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
AU752735B2 (en) Asthma and related disorders
AU2007202406B2 (en) Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
AU2011265475A1 (en) Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: GENAERA CORPORATION

Free format text: THE FORMER OWNER WAS: MAGAININ PHARMACEUTICALS, INC.

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE SECOND PRIORITY DETAILS TO READ 08/980872